Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy

SIMPLE SUMMARY: This paper presents a paradigm-shifted approach for adverse event (AE) analysis from classic descriptive summary into modern informative statistics to fulfill precision medicine. It defines early AE and derives a series of innovative AE biomarkers to assess grade, treatment relatedne...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dung-Tsa, Saltos, Andreas N., Rose, Trevor, Thompson, Zachary J., Thapa, Ram, Chiappori, Alberto, Gray, Jhanelle E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177532/
https://www.ncbi.nlm.nih.gov/pubmed/37173987
http://dx.doi.org/10.3390/cancers15092521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177532/
https://www.ncbi.nlm.nih.gov/pubmed/37173987
http://dx.doi.org/10.3390/cancers15092521

Ejemplares similares